Sonny Hsiao
Founder & Chief Executive Officer Acepodia Biotech
Seminars
Wednesday 14th October 2026
Showcasing Development & Application of Antibody Dual Drugs Conjugation (AD2C) Platform
11:30 am
- Introducing the advantages and differentiation of AD2C platform for ADC development
- Applying AD2C platform in development of anti-GPC3 ADCs with dual payloads for hepatocellular carcinoma treatment
